Bernard Coulie, M.D., Ph.D., M.B.A.

Bernard Coulie, M.D., Ph.D., M.B.A.

President, Chief Executive Officer and DirectoratPliant Therapeutics· In proxies 2021–2025

Pay in FY2025-17% from the year before · Pliant Therapeutics stock -90.7% the same year

Bernard Coulie, M.D., Ph.D., M.B.A. was paid $5.5M in FY2025 (Dec), down 17%. Pliant Therapeutics stock fell 90.7% that year.

Pay$100 in the stock at the end of FY20 → $5
Pay is from the Summary Compensation Table of each Pliant Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Pliant TherapeuticsPublic company · 5 yr
    • President, Chief Executive Officer and Director2021 – Present · 5 yrStock in role -96%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?